Active HD-tDCS
Active HD-tDCS is a medical device with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
HD-tDCS for Adolescent Bipolar Depression Targeting S1
HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial
HD-Tdcs and Pharmacological Intervention For Delirium In Critical Patients With COVID-19
Association of Inspiratory Muscle Training With HD-tDCS for Assistance to Patients With Long Covid-19
Modulation of an Experimental Prolonged Pain Model Using High Definition Transcranial Direct Current Stimulation
Clinical Trials (6)
HD-tDCS for Adolescent Bipolar Depression Targeting S1
HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial
HD-Tdcs and Pharmacological Intervention For Delirium In Critical Patients With COVID-19
Association of Inspiratory Muscle Training With HD-tDCS for Assistance to Patients With Long Covid-19
Modulation of an Experimental Prolonged Pain Model Using High Definition Transcranial Direct Current Stimulation
Patient Centered-Rehabilitation ver111090.1
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6